169 related articles for article (PubMed ID: 11309765)
1. Evaluation of artificial neural networks for the prediction of pathologic stage in prostate carcinoma.
Han M; Snow PB; Brandt JM; Partin AW
Cancer; 2001 Apr; 91(8 Suppl):1661-6. PubMed ID: 11309765
[TBL] [Abstract][Full Text] [Related]
2. Preoperative neural network using combined magnetic resonance imaging variables, prostate specific antigen and Gleason score to predict prostate cancer stage.
Poulakis V; Witzsch U; De Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
J Urol; 2004 Oct; 172(4 Pt 1):1306-10. PubMed ID: 15371829
[TBL] [Abstract][Full Text] [Related]
3. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and gleason score for predicting prostate cancer biochemical recurrence after radical prostatectomy.
Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
Urology; 2004 Dec; 64(6):1165-70. PubMed ID: 15596191
[TBL] [Abstract][Full Text] [Related]
4. Artificial neural network analysis for predicting pathological stage of clinically localized prostate cancer in the Japanese population.
Matsui Y; Egawa S; Tsukayama C; Terai A; Kuwao S; Baba S; Arai Y
Jpn J Clin Oncol; 2002 Dec; 32(12):530-5. PubMed ID: 12578902
[TBL] [Abstract][Full Text] [Related]
5. Novel staging tool for localized prostate cancer: a pilot study using genetic adaptive neural networks.
Tewari A; Narayan P
J Urol; 1998 Aug; 160(2):430-6. PubMed ID: 9679892
[TBL] [Abstract][Full Text] [Related]
6. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and Gleason score to predict positive surgical margins.
Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
Urology; 2004 Sep; 64(3):516-21. PubMed ID: 15351582
[TBL] [Abstract][Full Text] [Related]
7. A neural network predicts progression for men with gleason score 3+4 versus 4+3 tumors after radical prostatectomy.
Han M; Snow PB; Epstein JI; Chan TY; Jones KA; Walsh PC; Partin AW
Urology; 2000 Dec; 56(6):994-9. PubMed ID: 11113746
[TBL] [Abstract][Full Text] [Related]
8. Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.
Tosoian JJ; Chappidi M; Feng Z; Humphreys EB; Han M; Pavlovich CP; Epstein JI; Partin AW; Trock BJ
BJU Int; 2017 May; 119(5):676-683. PubMed ID: 27367645
[TBL] [Abstract][Full Text] [Related]
9. Validation of a biopsy-based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinoma.
Haese A; Epstein JI; Huland H; Partin AW
Cancer; 2002 Sep; 95(5):1016-21. PubMed ID: 12209685
[TBL] [Abstract][Full Text] [Related]
10. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.
Partin AW; Kattan MW; Subong EN; Walsh PC; Wojno KJ; Oesterling JE; Scardino PT; Pearson JD
JAMA; 1997 May; 277(18):1445-51. PubMed ID: 9145716
[TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients.
Polascik TJ; Manyak MJ; Haseman MK; Gurganus RT; Rogers B; Maguire RT; Partin AW
Cancer; 1999 Apr; 85(7):1586-92. PubMed ID: 10193950
[TBL] [Abstract][Full Text] [Related]
12. Preoperative neural network using combined magnetic resonance imaging variables, prostate specific antigen, and Gleason score to predict prostate cancer recurrence after radical prostatectomy.
Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
Eur Urol; 2004 Nov; 46(5):571-8. PubMed ID: 15474265
[TBL] [Abstract][Full Text] [Related]
13. Impact of different variables on the outcome of patients with clinically confined prostate carcinoma: prediction of pathologic stage and biochemical failure using an artificial neural network.
Ziada AM; Lisle TC; Snow PB; Levine RF; Miller G; Crawford ED
Cancer; 2001 Apr; 91(8 Suppl):1653-60. PubMed ID: 11309764
[TBL] [Abstract][Full Text] [Related]
14. Artificial neural network for predicting pathological stage of clinically localized prostate cancer in a Taiwanese population.
Tsao CW; Liu CY; Cha TL; Wu ST; Sun GH; Yu DS; Chen HI; Chang SY; Chen SC; Hsu CY
J Chin Med Assoc; 2014 Oct; 77(10):513-8. PubMed ID: 25175002
[TBL] [Abstract][Full Text] [Related]
15. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
Cagiannos I; Karakiewicz P; Eastham JA; Ohori M; Rabbani F; Gerigk C; Reuter V; Graefen M; Hammerer PG; Erbersdobler A; Huland H; Kupelian P; Klein E; Quinn DI; Henshall SM; Grygiel JJ; Sutherland RL; Stricker PD; Morash CG; Scardino PT; Kattan MW
J Urol; 2003 Nov; 170(5):1798-803. PubMed ID: 14532779
[TBL] [Abstract][Full Text] [Related]
16. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
[TBL] [Abstract][Full Text] [Related]
17. Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer.
Naito S; Kuroiwa K; Kinukawa N; Goto K; Koga H; Ogawa O; Murai M; Shiraishi T;
J Urol; 2008 Sep; 180(3):904-9; discussion 909-10. PubMed ID: 18635221
[TBL] [Abstract][Full Text] [Related]
18. Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancer.
Batuello JT; Gamito EJ; Crawford ED; Han M; Partin AW; McLeod DG; ODonnell C
Urology; 2001 Mar; 57(3):481-5. PubMed ID: 11248624
[TBL] [Abstract][Full Text] [Related]
19. [Establishment of artificial neural network model for predicting lymph node metastasis in patients with stage Ⅱ-Ⅲ gastric cancer].
Xue Z; Lu J; Lin J; Huang CM; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Zheng CH
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Apr; 25(4):327-335. PubMed ID: 35461201
[No Abstract] [Full Text] [Related]
20. Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer.
Karam JA; Svatek RS; Karakiewicz PI; Gallina A; Roehrborn CG; Slawin KM; Shariat SF
Clin Cancer Res; 2008 Mar; 14(5):1418-22. PubMed ID: 18316564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
